임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 예정· Multiple Myeloma (MM)A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
협력: 화이자
- 2상모집 예정· Metastatic Castrate Resistant Prostate Cancer (mCRPC)A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy
협력: 화이자
- 2상모집 중· Colitis, UlcerativeA Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
리드: 화이자
- 2상모집 예정· Metastatic (Stage IV) MelanomaClinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.
협력: 화이자
- 2상모집 중· OverweightA Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
리드: 화이자
- 2상모집 중· Prostate Cancer (Adenocarcinoma)A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
협력: 화이자
- 2상모집 중· Muscle-invasive Bladder CancerA Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
협력: 화이자
- 2상모집 중· Multiple MyelomaA Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
협력: 화이자
- 2상모집 중· Metastatic Breast Cancer ( HER2 Negative)Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
협력: 화이자
- 2상모집 중· Metastatic Renal Cell CarcinomaA Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
협력: 화이자
- 2상모집 중· Atopic DermatitisA Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
리드: 화이자
- 2상모집 중· Chronic Spontaneous UrticariaA Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
리드: 화이자
- 2상모집 중· Multiple Myeloma, Newly DiagnosedFrontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
협력: 화이자
- 2상모집 중· Refractory Multiple MyelomaOutpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
협력: 화이자
- 2상모집 중· Waldenstrom MacroglobulinemiaEfficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia
협력: 애브비, 화이자
- 2상모집 중· Multiple MyelomaSelf-administration of Subcutaneous Elranatamab in the Patients' Homes.
협력: 화이자
- 2상모집 중· Acute Lymphoblastic LeukemiaTherapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
협력: 암젠, 화이자
- 2상모집 중단 (진행 중)· Post-COVID ConditionStudy to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID
협력: 화이자
- 2상모집 중· Multiple MyelomaMeasurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
협력: 화이자
- 2상모집 중단 (진행 중)· Prostate CancerComeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
협력: 화이자
- 2상모집 중· Gram-negative Bacterial InfectionA Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
리드: 화이자 · 협력: 애브비
- 2상모집 중· Prostate AdenocarcinomaEffects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
협력: 화이자
- 2상모집 중단 (진행 중)· Pneumococcal DiseaseA Study to Learn About How a New Pneumococcal Vaccine Works in Infants
리드: 화이자
- 2상모집 중단 (진행 중)· Breast NeoplasmsA Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
리드: 화이자
- 2상모집 중· Smoldering Multiple MyelomaUse of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
협력: 화이자
- 2상모집 중단 (진행 중)· Metastatic Colorectal CancerStudy of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
협력: 화이자
- 2상모집 중· Diffuse Cutaneous Systemic SclerosisOpen Label Extension Study of Brentuximab Vedotin in Early dcSSc
협력: 화이자
- 2상모집 중단 (진행 중)· Advanced or Metastatic Breast CancerA Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
리드: 화이자
- 2상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
리드: 화이자
- 2상모집 중단 (진행 중)· Sickle Cell DiseaseAssessing Physical Function in Sickle Cell Patients Taking Voxelotor
협력: 화이자
- 2상모집 중단 (진행 중)· Diabetes Mellitus, Type 1Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
협력: 화이자
- 2상모집 중· ACUTE LYMPHOBLASTIC LEUKEMIAA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
리드: 화이자
- 2상모집 중단 (진행 중)· Metastatic Breast CancerA Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
협력: 화이자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.